Category: Parkinson’s News

Former Texas A&M basketball coach Billy Kennedy has spent his career developing game plans, mentoring players and leading teams through the highs and lows of competition. But in 2011, he faced an unexpected opponent in Parkinson’s disease, and he found hope in a place he jokingly calls “enemy territory” — the University of Kentucky.

Despite being a mainstay of Parkinson’s disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A recent human trial found that a new drug significantly reduces these effects, representing a breakthrough milestone in Parkinson’s treatment.

The Parkinson’s support group gathered to offer a platform for members to share, support, and connect with one another.

A recent study reveals an immune mechanism that could explain why Parkinson’s disease affects more men than women. This…

Solving a decades-long mystery.

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson’s and CNS treatments.

Cure Parkinson’s is supporting the Movers & Shakers new petition, alongside Parkinson’s UK and Spotlight YOPD, to call on the government to take

Harvey Silikovitz shared how a missed voicemail from a “Jeopardy!” producer in 2019 would delay his appearance on the show by more than five years.

A new study links rare ITSN1 mutations to a tenfold increase in Parkinson’s risk, paving the way for targeted treatments.

Parkinson’s disease cases are projected to double globally by 2050, reaching 25 million individuals, according to a recent modeling study published in BMJ. Population aging (increasing median age) emerged as a primary driver of this increase, followed by population growth (rising total number of people), with the largest increases expected in East Asia and among people aged 80 and older.